AbbVie Raises FY23 Adjusted EPS Guidance From $10.57-$10.97 To $10.90-$11.10 Versus Consensus Of $10.85
Portfolio Pulse from Benzinga Newsdesk
AbbVie has increased its FY23 adjusted EPS guidance from $10.57-$10.97 to $10.90-$11.10, which is higher than the consensus of $10.85.
July 27, 2023 | 11:41 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
AbbVie's raised FY23 adjusted EPS guidance is likely to positively impact its stock price in the short term.
AbbVie's raised EPS guidance for FY23 indicates better-than-expected profitability, which is a positive signal to investors. This could lead to increased demand for the stock, thereby driving up its price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100